உற்பத்தி சவால்கள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from உற்பத்தி சவால்கள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In உற்பத்தி சவால்கள் Today - Breaking & Trending Today

Aruvant to Participate in Numerous Scientific and Investor Conferences in February and March


Press release content from PR Newswire. The AP news staff was not involved in its creation.
Aruvant to Participate in Numerous Scientific and Investor Conferences in February and March
February 11, 2021 GMT
(PRNewsfoto/Aruvant Sciences)
NEW YORK and BASEL, Switzerland, Feb. 11, 2021 /PRNewswire/ Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative gene therapies for the treatment of rare diseases, today announced management participation in multiple investor and scientific conferences in February and March. The company will be at the following conferences:
BIO CEO & Investor Digital Conference. Will Chou, M.D., Aruvant chief executive officer, will provide an overview of Aruvant and review data examining the company’s lead product candidate ARU-1801 as a potentially curative gene therapy for sickle cell disease. Visit https://www.bio.org/events/bio-ceo-investor-digital-conference/sessions/770479 to vi ....

Prnewswire Aruvant , Instagram Aruvant , Palani Palaniappan , Joseph Mcintosh , Aruvant Sciences , Will Chou , Annual Leerink Global Healthcare , Annual Gene Therapy , Gene Therapy , Manufacturing Challenges , Corporate News , Products And Services , Health Care Industry , Pr Newswire , Product Testing , Genetics Research , Clinical Trials , Diagnosis And Treatment , Sickle Cell Disease , Diseases And Conditions , Medical Research , Medical Biotechnology Industry , பழநி பழனியப்பன் , ஜோசப் ம்ஸிஂடோஶ் , விருப்பம் ச Ou , ஆண்டு கீந் சிகிச்சை ,